pca 4230 has been researched along with thromboxane b2 in 1 studies
| Studies (pca 4230) | Trials (pca 4230) | Recent Studies (post-2010) (pca 4230) | Studies (thromboxane b2) | Trials (thromboxane b2) | Recent Studies (post-2010) (thromboxane b2) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 7,483 | 715 | 485 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gutiérrez Díaz, JA; Ortega, MP; Priego, JG; Sunkel, C; Tolón, RM | 1 |
1 other study(ies) available for pca 4230 and thromboxane b2
| Article | Year |
|---|---|
Interaction of platelets with subendothelium in rats treated with PCA-4230, a new antithrombotic agent. Effect of PCA-4230 on experimental thrombosis.
Topics: Animals; Blood Platelets; Carotid Arteries; Dihydropyridines; Fibrinogen; Fibrinolytic Agents; Male; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Thrombosis; Thromboxane B2; Ticlopidine | 1992 |